ANET Electrosurgery Applicator Pilot Evaluation Study
Sponsor: Olympus Corporation of the Americas
Terminated
business reason
Other terminated trials from Olympus Corporation of the Americas
See all terminations from Olympus Corporation of the Americas
Listed as NCT03400748, this NA trial focuses on Lung Cancer and Lung Cancer Metastatic and remains terminated or withdrawn. Sponsored by Olympus Corporation of the Americas, it has been updated 18 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2024 — Jul 2024 [monthly]
Terminated NA
-
Oct 2023 — May 2024 [monthly]
Terminated NA
-
Jan 2023 — Oct 2023 [monthly]
Terminated NA
▶ Show 13 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Oct 2021 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Oct 2021 [monthly]
Terminated NA
-
Dec 2020 — Jan 2021 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Apr 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2019 — Apr 2020 [monthly]
Recruiting NA
-
Nov 2019 — Dec 2019 [monthly]
Recruiting NA
-
Sep 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jul 2019 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2019 — Jul 2019 [monthly]
Recruiting NA
-
Aug 2018 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Olympus Corporation of the Americas
For direct contact, visit the study record on ClinicalTrials.gov .